EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model

Cystische Fibrose Learning Network Telehealth Innovation Lab während der COVID-19-Pandemie: Auswirkungen auf den Zugang zur Versorgung, Outcomes und ein neues CF-Versorgungsmodell

Dana Albon, Thida Ong, Bethany Horton, David Brighton, Shiyi Shen, Rhonda List, Nicholas Antos, Fadi Asfour, Ella Balasa, Danielle Beachler, Cori Daines, Deborah Froh und 7 weitere

Pediatric Pulmonology · 2025-05 · 60 (5)

DOI: 10.1002/ppul.71102 ↗

Auf einen Blick

Bei Menschen mit zystischer Fibrose war im CFLN TH-iLab die Telehealth-Nutzung höher als in den Vergleichsgruppen. Klinische Outcomes blieben dabei ähnlich.

Fragestellung

Ist eine standardisierte Telehealth-Implementierung im CFLN TH-iLab mit besserem Zugang zur CF-Versorgung und ähnlichen Lungenfunktions- und Ernährungsoutcomes verbunden?

Methode

Auswertung aller Personen mit CF im CF Foundation Registry von 1/2020 bis 12/2021; Vergleich von CFLN TH-iLab, CFLN TH-iLab-Non-Teilnehmenden und Nicht-CFLN-Programmen.

Ergebnisse

2020 und 2021 waren die mittlere Zahl der Telehealth-Besuche pro Person/Jahr und der Anteil mit ≥1 Telehealth-Besuch im CFLN TH-iLab höher. Lungenfunktion, Anthropometrie, Spirometrie und Kulturen waren ähnlich.

Schlussfolgerung der Autor:innen

Die Integration von Telehealth in die CF-Versorgung im CFLN TH-iLab ermöglichte während der COVID-19-Pandemie Zugang zur Versorgung, ohne klinische Outcomes zu beeinträchtigen.

Kernaussagen

  • Telehealth-Nutzung war im CFLN TH-iLab höher als in den Vergleichsgruppen.
  • Klinische Outcomes blieben zwischen den Gruppen ähnlich.
  • Zugang zur interdisziplinären Versorgung war im CFLN Non-TH-iLab am höchsten.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 05.05.2025. Verfasst von Dana Albon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, COVID-19, Telemedicine, Health Services Accessibility. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was grant support by CFF 004212322 - Albon; CFF SEID19AB0., Cystic Fibrosis Foundation.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystic fibrosis (CF) is a chronic genetic disorder requiring regimented visits for maintenance of care. The COVID‐19 pandemic accelerated the accessibility of telehealth (TH) and forced a trial of incorporating remote care into routine CF care. The CF Learning Network (CFLN) organized for data sharing into a telehealth innovation lab (TH‐iLab) to improve access to the interdisciplinary care team and co‐produced shared agenda‐setting.

Methods

All persons with CF (PwCF) with a CF diagnosis in the CF Foundation Registry (CFFPR) from 1/2020–12/2021 were included and categorized into CFLN TH‐iLab, CFLN TH‐iLab non‐participants, and non‐CFLN programs. Hypothesis: standardized TH implementation in the CFLN TH‐iLab is associated with increased access to the CF care model and results in similar lung function and nutrition health outcomes.

Results

In 2020 and 2021, the average number of TH visits per person per year and the percentage of PwCF with one or more TH visits per year were higher in the CFLN TH‐iLab than in the other groups. Lung function was highest in PwCF, followed by a program that was part of the CFLN TH‐iLab in 2020 and 2021. Anthropometric measurements, spirometry, and attainment of microbiology cultures were similar among all three groups. Access to interdisciplinary care was highest in the CFLN non‐TH‐iLab group.

Conclusion

Integrating TH into CF care in the CFLN TH‐iLab provided access to care during the COVID‐19 pandemic without compromising clinical outcomes. Further research on optimizing the telehealth experience for PwCF can help better understand TH's long‐term impact on CF care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCOVID-19TelemedicineHealth Services AccessibilityHumansFemaleChildMaleSARS-CoV-2AdolescentRegistriesAdultPandemics

Stichwörter der Autor:innen

cystic fibrosiscystic fibrosis learning networkinnovation laboratoryquality improvementtelehealth

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.
  • Seattle Children's Hospital, Pulmonary and Sleep Medicine, University of Washington School of Medicine, Pediatrics, Seattle, Washington, USA.
  • Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Pediatrics, The University of Utah, Salt Lake City, Utah, USA.
  • Virginia Commonwealth University, Pulmonary and Critical Care, Richmond, Virginia, USA.

Förderung

  • This study was grant support by CFF 004212322 - Albon; CFF SEID19AB0.
  • Cystic Fibrosis Foundation

Zitieren

APA

Albon, D., Ong, T., Horton, B., Brighton, D., Shen, S., List, R., Antos, N., Asfour, F., Balasa, E., Beachler, D., Daines, C., Froh, D., Kier, C., Nasr, S., Sathe, M., Sawicki, G., Schechter, M., Solomon, G., & Powers, M. (2025). Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric Pulmonology, 60(5). https://doi.org/10.1002/ppul.71102

Vancouver

Albon D, Ong T, Horton B, Brighton D, Shen S, List R, et al. Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric Pulmonology. 2025;60(5). doi:10.1002/ppul.71102

BibTeX
@article{Albon2025,
  author = {Albon, Dana and Ong, Thida and Horton, Bethany and Brighton, David and Shen, Shiyi and List, Rhonda and Antos, Nicholas and Asfour, Fadi and Balasa, Ella and Beachler, Danielle and Daines, Cori and Froh, Deborah and Kier, Catherine and Nasr, Samya and Sathe, Meghana and Sawicki, Gregory and Schechter, Michael and Solomon, George and Powers, Michael},
  title = {Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model},
  journal = {Pediatric Pulmonology},
  year = {2025},
  volume = {60},
  number = {5},
  doi = {10.1002/ppul.71102}
}
Kostenlos starten →